Other genes, such as DUSP22 (an immediate neighbor of IRF4 on chr6p25.3), ATP6AP1, FPGS, DPM2, and TAFAZZIN, warrant further investigation as potential therapeutic targets in MM. This evidence concerns the gene IRF4 and Miyoshi myopathy.